Abstract:
본 발명은 락토바실러스 퍼멘텀( L. fermentum ) LC272 균주를 이용한 비타민 K 2 의 생산 최적화 방법을 제공한다. 본 발명은 락토바실러스 퍼멘텀 LC272 균주와, 락토바실러스 에시도필러스( L. acidophilus ), 비피도박테리움 롱검( B. longum ) 및 스트렙토코커스 서머필러스( S. thermophilus )로 이루어지는 혼합균주를 이용한 발효유 제조 방법을 제공한다. 본 발명의 방법에 의해 제조된 발효유는 다량의 비타민 K 2 를 포함하며, 골형성을 증가시킨다.
Abstract:
PURPOSE: Processed cheese containing omega 3 fatty acid and a manufacturing method thereof are provided to restrict greasy taste of the cheese by mixing the additives at a proper rate, and to improve preference of the chesses using an optimized content of the omega 3 fatty acid. CONSTITUTION: Processed cheese contains omega 3 fatty acid produced from marine microorganism. A manufacturing method of the processed cheese containing the omega 3 fatty acid comprises a step for adding the omega 3 fatty acid produced from the marine microorganism in ingredients, a step for mixing one or more chesses such as Mozzarella or Cheddar with refined water, sodium caseinate, butter etc with the ingredients, and a step for solidifying and agitating the mixed additives in 80-90°C.
Abstract:
PURPOSE: Fermented milk using Lactobacillus plantarum M23 and a manufacturing method thereof are provided to reduce manufacturing costs of the fermented milk with stable supply of spawn, and to improvemelanin formation inhibition capability. CONSTITUTION: Fermented milk includes Lactobacillus plantarum M23. A manufacturing method of the fermented milk includes a step for inoculating the Lactobacillus plantarum M23 to raw milk, a step for agitating and mixing 70 ~ 90 weight% fermented liquid and 10 ~ 30 weight% of secondary materials, and a step for storing the fermented milk in a wrapping pack.
Abstract:
PURPOSE: Fermented milk including Lactobacillus zeae RMK354 and a manufacturing method thereof are provided to offer good ACE inhibiting activity capability, and to reduce manufacturing costs of the fermented milk due to stable supply of the fermented milk. CONSTITUTION: Fermented milk includes Lactobacillus zeae KACC 91314P. A manufacturing method of the fermented milk includes a step for inoculating Lactobacillus zeae KACC 91314P to raw milk, a step for agitating and mixing 70 ~ 90 weight% fermented liquid and 10 ~ 30 weight% of secondary materials, and a step for storing the fermented milk in a wrapping pack.
Abstract:
본 발명은 신규한 엔테로코커스 휘칼리스 RMB46 균주에 관한 것으로, 더욱 상세하게는 발효유 제조에 적합한 젖산 및 ACE 억제 활성능력이 있는 신규한 젖산균인 엔테로코커스 휘칼리스( Enterococcus faecalis ) RMB46에 관한 것이다. 본 발명의 젖산균은 종래에 발견된 젖산 발효균보다 ACE 억제 활성 능력이 뛰어나며, 발효유를 제조하는데 적합하다. ACE, 발효유, 엔테로코커스 휘칼리스
Abstract:
Enterococcus faecalis RMB46 strain is provided to have an ACE inhibiting capability higher than that of a lactic acid zymogen by have ACE restraint capability, to be suitable to manufacture fermented milk and to have an excellent milk clotting power. Enterococcus faecalis RMB46(KACC 91313P) is strain having an excellent solidification rate and an ACE restraint capability in coagulation strains of skim milk. A method of manufacturing the Enterococcus faecalis RMB46(KACC 91313P) comprises steps of: purely separating each colony and selecting the colony changing into yellow to temporary lactic acid bacteria after cultivating a deformed MRS in raw milk; and purely separating the selected strain by being aerotropic-cultivated after the selected strain is painted out in an electrostriction MRS culture medium.
Abstract:
A novel strain of Lactobacillus zeae RMK354 is provided to improve milk coagulation activity and ACE(angiotensin converting enzyme) inhibitory activity as compared to conventional lactic acid bacteria, so that the strain is suitable for production of functional fermented milk. A novel strain of Lactobacillus zeae RMK354(KACC 91314P) showing improved milk coagulation activity and ACE inhibitory activity is isolated from raw milk by culturing the raw milk in modified MRS(Modified Rogosa SL) medium, isolating yellow colonies as lactic acid bacteria, selecting skim milk-coagulating strains, and selecting a strain showing excellent ACE inhibitory activity from the selected skim milk-coagulating strains, shows optimal temperature of 40 deg. C and needs 10 hours until a pH reaches 4.3 to 4.4 which is optimal pH of fermented milk.
Abstract:
본 발명은 흰털오가피 추출물을 유효성분으로 함유하는 발효유 조성물과 그 제조방법을 제공한다. 상기 본 발명의 발효유는 기호성 및 기능성이 우수하다. 또한 본 발명에 따른 발효유 제조방법은 원유 또는 원유와 탈지분유의 혼합균질유에 발효 스타터를 접종하여 소정의 산도가 될 때까지 배양시키는 단계; 및 전기 단계에서 얻어진 발효유에 흰털오가피 추출물 단독, 또는 흰털오가피 추출물과 더덕 추출물을 함께 첨가시켜 혼합한 후 균질화 하는 단계를 포함한다. 흰털오가피, 발효유
Abstract:
A method of manufacturing fermented milk containing strains of Lactobacillus crispatus RMK 567(KCCM 10745P) is provided to reduce the cost of production and produce fermented milk having excellent gamma-aminobutyric acid producing capability as well as excellent palatability in color, taste and texture. First, 0 to 100% by weight of raw milk, 0 to 10% by weight of nonfat dry milk and 0.1 to 1% by weight of MSG are mixed at 55 to 65deg.C, homogenized at a pressure of 180 to 250kgf/cm^2, sterilized at 85 to 95deg.C for 5 to 30min and cooled to 35 to 45deg.C. Secondly, the obtained culture medium is inoculated with 0.5 to 1.0% by weight of strains of Lactobacillus crispatus RMK 567, cultured until the final pH is reduced to 4.3 to 4.6 and cooled to 15 to 20deg.C. Finally, the culture is additionally added with 3.0 to 7.0% by weight of oligosaccharide, 1.0 to 5.0% by weight of high fructose corn syrup, 1.0 to 10.0% by weight of purified water and 4 to 10% by weight of strawberry jam or blueberry jam.
Abstract:
본 발명은 고칼슘 멸치분말의 제조방법에 관한 것으로서 보다 상세하게는 멸치를 주정과 유기산으로 처리하여 색택이 우수하고 비린내가 감소될 뿐만 아니라 칼슘흡수율이 높은 고칼슘 멸치분말의 제조방법에 관한 것이다. 본원은 멸치를 분말화한 후 주정과 유기산으로 처리하여 색택이 우수하고 비린내가 감소될 뿐만 아니라 칼슘흡수율이 높은 고칼슘 멸치분말의 제조방법 제공을 목적으로 한다. 본 발명에 의해 칼슘흡수율이 높은 고칼슘 멸치분말은 두부, 우유를 비롯한 다른 식품에 고칼슘 소재로 첨가할 수 있다. 본 발명의 멸치분말 제조방법은 멸치를 분쇄하여 분말화하는 단계, 멸치분말을 주정에 침지한 다음 여과 및 수세하여 주정을 제거하는 단계, 주정을 제거한 멸치분말을 건조하는 단계, 건조한 멸치분말을 유기산에 침지한 다음 건조하는 단계를 포함한다.